[Evaluation and treatment of gastroesophageal reflux in infants and children].
Gastroesophageal reflux (GER), defined as passage of gastric contents into esophagus, and GER disease (GERD), defined as symptoms or complications of GER, are common pediatric problems encountered by both primary and specialty medical providers. Clinical manifestations of GERD in children include vomiting, poor weight gain, dysphagia, abdominal or substernal pain, esophagitis and respiratory disorders. On the other hand, recurrent vomiting is the symptom of hydronephrosis, brain tumor, food allergy, uremia, other metabolic disease, obstruction of intestine etc. It is very important for clinicians dealing with children and infants to understand GERD. The evaluation and treatment of gastroesophageal reflux in infants and children were reviewed here.
Ida
Shinobu
S
Division of Pediatric Gastroenterology, Nutrition and Endocrinology, Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health.
D001249:Asthma / Q000209:etiology; D001471:Barrett Esophagus / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D013505:Digestive System Surgical Procedures; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004942:Esophagitis, Peptic / Q000209:etiology; D005764:Gastroesophageal Reflux / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006551:Hernia, Hiatal / Q000209:etiology; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D010535:Laparoscopy; D011187:Posture; D054328:Proton Pump Inhibitors; D013398:Sudden Infant Death / Q000209:etiology; D013577:Syndrome; D014103:Torticollis / Q000209:etiology
D004791:Enzyme Inhibitors; D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors